News

Deal Announcements

CoAxia Clears Series D Venture Capital Investment

Thursday, June 25, 2009 5:39:00 AM PDT | VentureDeal Staff
Maple Grove, Minnesota  --  Medical device company CoAxia has secured $21.5 million for its fourth round of venture capital financing.

CoAxia says that it is "pioneering the use of catheter-based perfusion augmentation systems for the treatment of cerebral ischemia."

Sofinnova Ventures led the round, which also included Affinity Capital, Baird Venture Partners, Canaan Partners, Johnson & Johnson Development Corporation and Prism VentureWorks.  Proceeds purposes from the financing were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1